3Indexed trials
drug · Product Intelligence
Duloxetine Hydrochloride
Pipeline Intelligence
Duloxetine Hydrochloride: 3 indexed trials, 1 sponsors; 1 linked Orange Book patents and 8 FDA-linked events where matched.
1Sponsors
1Orange Book patent links
8FDA-linked events
Development evidence
NCT00036309Eli Lilly and Company · depressionPHASE3
NCT00071708Eli Lilly and Company · depressionAPPROVED_FOR_MARKETING
NCT00810069Eli Lilly and Company · depressionPHASE4
FDA / patent evidence
12721817DULOXETINE HYDROCHLORIDE · app 2191312046-01-13
Regulatory context
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2026-02-27
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2019-08-16
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2019-04-17
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2017-03-23
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2015-10-28
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2015-08-26
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2014-06-09
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2013-12-11
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.